State NJ
Clinical Trials in New Jersey
Recruiting clinical trials with at least one study location in New Jersey. Data updated daily from ClinicalTrials.gov.
Top Conditions in New Jersey
NCT03907046 Phase 3
Recruiting
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Condition
Intracerebral Hemorrhage
Enrollment
700 pts
Location
United States
Sponsor
Yale University
NCT07122739 N/A
Recruiting
Neurofeedback to Reduce Spontaneous Recovery of Threat Expectancy
Condition
Healthy
Enrollment
40 pts
Location
United States
Sponsor
Trustees of Princeton Universi
NCT06377566 Phase 2
Recruiting
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
Condition
Hodgkin Lymphoma
Enrollment
71 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT05925101 N/A
Recruiting
Basic and Applied Research on Extinction Bursts
Condition
Problem Behavior
Enrollment
40 pts
Location
United States
Sponsor
Rutgers, The State University
NCT06317662 Phase 2
Recruiting
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer I...
Condition
Acute Leukemia of Ambiguous Lineage
Enrollment
153 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT06781983 Phase 1
Recruiting
Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors
Condition
Advanced or Metastatic Solid Tumors
Enrollment
145 pts
Location
United States, France
Sponsor
Innate Pharma
NCT06660654 Phase 2
Recruiting
A Study of Raludotatug Deruxtecan in Participants With Advanced/Metastatic Solid...
Condition
Advanced Solid Tumor
Enrollment
200 pts
Location
United States, Belgium, China
Sponsor
Daiichi Sankyo
NCT05307939 Phase 2
Recruiting
A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRout...
Condition
HPV
Enrollment
30 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT06664619 Phase 3
Recruiting
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of F...
Condition
Asthma
Enrollment
724 pts
Location
United States, Argentina, Bulgaria
Sponsor
Teva Branded Pharmaceutical Pr
NCT05853367 Phase 1
Recruiting
Study of MK-0472 in Participants With Advanced/Metastatic Solid Tumors (MK-0472-...
Condition
Metastatic Solid Tumors
Enrollment
178 pts
Location
United States, Canada, Chile
Sponsor
Merck Sharp & Dohme LLC
NCT05174169 Phase 2, Phase 3
Recruiting
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Condition
Stage III Colon Cancer
Enrollment
1,912 pts
Location
United States, Canada, Puerto Rico
Sponsor
NRG Oncology
NCT05736419 Phase 2
Recruiting
A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β...
Condition
Sickle Cell Disease
Enrollment
24 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT05304767 Phase 3
Recruiting
An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive Kar...
Condition
Schizophrenia
Enrollment
280 pts
Location
United States, Bulgaria, Czechia
Sponsor
Karuna Therapeutics, Inc., a B
NCT07227636 Phase 2
Recruiting
A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After ...
Condition
Colorectal Cancer
Enrollment
284 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT07063979 N/A
Recruiting
Use of Transcutaneous Electrical Nerve Stimulation Device, Reletex Reliefband, W...
Condition
Postoperative Nausea and Vomiting
Enrollment
100 pts
Location
United States
Sponsor
University of Pennsylvania
NCT04485559 Phase 1
Recruiting
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients Wi...
Condition
Recurrent World Health Organization (WHO) Grade II Glioma
Enrollment
50 pts
Location
United States
Sponsor
University of California, San
NCT05076942 Phase 2
Recruiting
Groningen International Study on Sentinel Nodes in Vulvar Cancer-III
Condition
Vulvar Cancer
Enrollment
157 pts
Location
United States, Netherlands
Sponsor
University Medical Center Gron
NCT06440577 N/A
Recruiting
Craving & Decision-Making
Condition
Decision Making
Enrollment
160 pts
Location
United States
Sponsor
Rutgers, The State University
NCT07483307 Phase 2
Recruiting
A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With B...
Condition
Breast Cancer
Enrollment
176 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT06253871 Phase 1
Recruiting
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Condition
HER2 Mutation-Related Tumors
Enrollment
243 pts
Location
United States, France, Ireland
Sponsor
Iambic Therapeutics, Inc
NCT06321302 Phase 2
Recruiting
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diab...
Condition
Diabetic Retinopathy
Enrollment
178 pts
Location
United States, Germany, Hungary
Sponsor
Boehringer Ingelheim
NCT05491512 Phase 2
Recruiting
A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People...
Condition
HPV
Enrollment
121 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT05519072 Phase 4
Recruiting
Use of Prophylactic Antibiotics Prior to OnabotulinumtoxinA
Condition
Antibiotic Prophylaxis
Enrollment
140 pts
Location
United States
Sponsor
Atlantic Health System
NCT05642572 Phase 2
Recruiting
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer...
Condition
Recurrent Lung Non-Small Cell Carcinoma
Enrollment
66 pts
Location
United States
Sponsor
SWOG Cancer Research Network
NCT06058039 Phase 3
Recruiting
Study to Assess the Effects of Oral NMRA-335140 in Participants With Major Depre...
Condition
Major Depressive Disorder
Enrollment
332 pts
Location
United States, Bulgaria, Czechia
Sponsor
Neumora Therapeutics, Inc.